In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy

C. L. Stabler, R. C. Long, I. Constantinidis, A. Sambanis

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Direct, noninvasive monitoring of tissue engineered substitutes containing live, functional cells would provide valuable information on dynamic changes that occur postimplantation. Such changes include remodeling both within the construct and at the interface of the implant with the surrounding host tissue, and may result in changes in the number of viable cells in the construct. This study investigated the use of 1H NMR spectroscopy in noninvasively monitoring the viable cell number within a tissue engineered construct in vivo. The construct consisted of mouse βTC3 insulinomas in a disk-shaped agarose gel, surrounded by a cell-free agarose gel layer. Localized 1H NMR spectra were acquired from within implanted constructs, and the total choline resonance was measured. Critical issues that had to be addressed in accurately quantifying total choline from the implanted cells included avoiding signal from host tissue and correcting for interfering signal from diffusing solutes. In vivo NMR measurements were correlated with MTT assays and NMR measurements performed in vitro on explanted constructs. Total choline measurements accurately and noninvasively quantified viable βTC3 cell numbers in vivo, in the range of 1 × 106 to more than 14 × 106 cells, and monitored changes in viable cell number that occurred in the same construct over time. This is the first study using NMR techniques to monitor viable cell numbers in an implanted tissue substitute. It established architectural characteristics that a construct should have to be amenable to NMR monitoring, and it set the foundation for future in vivo investigations with other tissue engineered implants.

Original languageEnglish
Pages (from-to)139-149
Number of pages11
JournalCell Transplantation
Volume14
Issue number2-3
StatePublished - May 13 2005

Fingerprint

Nuclear magnetic resonance spectroscopy
Magnetic Resonance Spectroscopy
Tissue
Cell Count
Nuclear magnetic resonance
Monitoring
Choline
Sepharose
Gels
Insulinoma
Proton Magnetic Resonance Spectroscopy
Assays

Keywords

  • βTC3 insulinoma cells
  • H NMR spectroscopy
  • In vivo monitoring
  • Pancreatic substitute
  • Total choline

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Stabler, C. L., Long, R. C., Constantinidis, I., & Sambanis, A. (2005). In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy. Cell Transplantation, 14(2-3), 139-149.

In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy. / Stabler, C. L.; Long, R. C.; Constantinidis, I.; Sambanis, A.

In: Cell Transplantation, Vol. 14, No. 2-3, 13.05.2005, p. 139-149.

Research output: Contribution to journalArticle

Stabler, CL, Long, RC, Constantinidis, I & Sambanis, A 2005, 'In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy', Cell Transplantation, vol. 14, no. 2-3, pp. 139-149.
Stabler CL, Long RC, Constantinidis I, Sambanis A. In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy. Cell Transplantation. 2005 May 13;14(2-3):139-149.
Stabler, C. L. ; Long, R. C. ; Constantinidis, I. ; Sambanis, A. / In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy. In: Cell Transplantation. 2005 ; Vol. 14, No. 2-3. pp. 139-149.
@article{4d58bda277d342be824890cc708691b8,
title = "In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy",
abstract = "Direct, noninvasive monitoring of tissue engineered substitutes containing live, functional cells would provide valuable information on dynamic changes that occur postimplantation. Such changes include remodeling both within the construct and at the interface of the implant with the surrounding host tissue, and may result in changes in the number of viable cells in the construct. This study investigated the use of 1H NMR spectroscopy in noninvasively monitoring the viable cell number within a tissue engineered construct in vivo. The construct consisted of mouse βTC3 insulinomas in a disk-shaped agarose gel, surrounded by a cell-free agarose gel layer. Localized 1H NMR spectra were acquired from within implanted constructs, and the total choline resonance was measured. Critical issues that had to be addressed in accurately quantifying total choline from the implanted cells included avoiding signal from host tissue and correcting for interfering signal from diffusing solutes. In vivo NMR measurements were correlated with MTT assays and NMR measurements performed in vitro on explanted constructs. Total choline measurements accurately and noninvasively quantified viable βTC3 cell numbers in vivo, in the range of 1 × 106 to more than 14 × 106 cells, and monitored changes in viable cell number that occurred in the same construct over time. This is the first study using NMR techniques to monitor viable cell numbers in an implanted tissue substitute. It established architectural characteristics that a construct should have to be amenable to NMR monitoring, and it set the foundation for future in vivo investigations with other tissue engineered implants.",
keywords = "βTC3 insulinoma cells, H NMR spectroscopy, In vivo monitoring, Pancreatic substitute, Total choline",
author = "Stabler, {C. L.} and Long, {R. C.} and I. Constantinidis and A. Sambanis",
year = "2005",
month = "5",
day = "13",
language = "English",
volume = "14",
pages = "139--149",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "2-3",

}

TY - JOUR

T1 - In vivo noninvasive monitoring of a tissue engineered construct using 1H NMR spectroscopy

AU - Stabler, C. L.

AU - Long, R. C.

AU - Constantinidis, I.

AU - Sambanis, A.

PY - 2005/5/13

Y1 - 2005/5/13

N2 - Direct, noninvasive monitoring of tissue engineered substitutes containing live, functional cells would provide valuable information on dynamic changes that occur postimplantation. Such changes include remodeling both within the construct and at the interface of the implant with the surrounding host tissue, and may result in changes in the number of viable cells in the construct. This study investigated the use of 1H NMR spectroscopy in noninvasively monitoring the viable cell number within a tissue engineered construct in vivo. The construct consisted of mouse βTC3 insulinomas in a disk-shaped agarose gel, surrounded by a cell-free agarose gel layer. Localized 1H NMR spectra were acquired from within implanted constructs, and the total choline resonance was measured. Critical issues that had to be addressed in accurately quantifying total choline from the implanted cells included avoiding signal from host tissue and correcting for interfering signal from diffusing solutes. In vivo NMR measurements were correlated with MTT assays and NMR measurements performed in vitro on explanted constructs. Total choline measurements accurately and noninvasively quantified viable βTC3 cell numbers in vivo, in the range of 1 × 106 to more than 14 × 106 cells, and monitored changes in viable cell number that occurred in the same construct over time. This is the first study using NMR techniques to monitor viable cell numbers in an implanted tissue substitute. It established architectural characteristics that a construct should have to be amenable to NMR monitoring, and it set the foundation for future in vivo investigations with other tissue engineered implants.

AB - Direct, noninvasive monitoring of tissue engineered substitutes containing live, functional cells would provide valuable information on dynamic changes that occur postimplantation. Such changes include remodeling both within the construct and at the interface of the implant with the surrounding host tissue, and may result in changes in the number of viable cells in the construct. This study investigated the use of 1H NMR spectroscopy in noninvasively monitoring the viable cell number within a tissue engineered construct in vivo. The construct consisted of mouse βTC3 insulinomas in a disk-shaped agarose gel, surrounded by a cell-free agarose gel layer. Localized 1H NMR spectra were acquired from within implanted constructs, and the total choline resonance was measured. Critical issues that had to be addressed in accurately quantifying total choline from the implanted cells included avoiding signal from host tissue and correcting for interfering signal from diffusing solutes. In vivo NMR measurements were correlated with MTT assays and NMR measurements performed in vitro on explanted constructs. Total choline measurements accurately and noninvasively quantified viable βTC3 cell numbers in vivo, in the range of 1 × 106 to more than 14 × 106 cells, and monitored changes in viable cell number that occurred in the same construct over time. This is the first study using NMR techniques to monitor viable cell numbers in an implanted tissue substitute. It established architectural characteristics that a construct should have to be amenable to NMR monitoring, and it set the foundation for future in vivo investigations with other tissue engineered implants.

KW - βTC3 insulinoma cells

KW - H NMR spectroscopy

KW - In vivo monitoring

KW - Pancreatic substitute

KW - Total choline

UR - http://www.scopus.com/inward/record.url?scp=18044378158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044378158&partnerID=8YFLogxK

M3 - Article

C2 - 15881423

AN - SCOPUS:18044378158

VL - 14

SP - 139

EP - 149

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 2-3

ER -